ArticlePharmaceutics2026

Model-Based Virtual Clinical Trial Reveals Renal Impairment and Body Size as Key Determinants of Pharmacokinetic Variability and Drug-Drug Interaction Risk in Propranolol Therapy.

Lara Marques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.